Abstract:The activity of HIV-1 and its viral proteins within the central nervous system (CNS) is responsible for a wide array of neuropathological effects, resulting in a spectrum of neurocognitive deficits defined as HIV-associated neurocognitive disorders (HAND). Amongst the various viral proteins, the transactivator of transcription (Tat) remains detectable even with effective antiretroviral therapy (ART) and suppressed viremia, highlighting the significance of this protein in the modern ART era. Tat has been extensively researched in both fundamental and clinical settings due to its role in neuroinflammation, neuronal damage, and neurocognitive impairment amongst people living with HIV (PLHIV). To date, numerous fundamental studies have explored Tat-induced neuroinflammation. However, there is no clear consensus on the most frequently studied inflammatory markers or the consistency in the levels of these Tat-induced inflammatory marker levels across different studies. Therefore, we conducted a scoping review of studies investigating Tat-induced neuroinflammation. We conducted searches in PubMed, Scopus, and Web of Science databases using a search protocol tailored specifically to adhere to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for scoping reviews (PRISMA-ScR) guidelines. From the 22 included studies, findings suggest that the HIV-1 Tat protein amplifies levels of neuroinflammatory markers. Amongst the vast array of inflammatory markers explored in the included studies, consistent results point to higher levels of CCL2, IL-6, IL-8, and TNF-α in primary cells and cell lines exposed to or transfected with HIV-1 Tat. These markers are regulated by key inflammatory pathways, such as the extracellular signal-regulated kinase (ERK)1/2 mitogen-activated protein kinase (MAPK) pathway, the phosphatidylinositol 3-kinase (PI3K) pathway, the p38 MAPK pathway, and nuclear factor-kB (NF-kB). Furthermore, Tat has been shown to induce neuronal apoptosis, both directly and indirectly. With regards to study designs, utilizing full-length Tat101 at concentrations ranging from 100 to 1000 ng/ml and durations of 24 and 48 h appears optimal for investigating Tat-induced neuroinflammation. In this context, we highlight specific inflammatory markers and pathways that are potentially pivotal in Tat-induced neuroinflammation and subsequent neuronal damage. A deeper investigation into these markers and pathways is crucial to better understand their roles in the development of HAND.

Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein

Development of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 Latency

Nuclear Factor of Activated T Cells and Cytokines Gene Expression of the T Cells in AIDS Patients with Immune Reconstitution Inflammatory Syndrome During Highly Active Antiretroviral Therapy

Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis

Transactivator of Transcription (Tat)-Induced Neuroinflammation as a Key Pathway in Neuronal Dysfunction: A Scoping Review

HIV-1 Tat: Role in Bystander Toxicity

Human Immunodeficiency Virus (HIV)-1 Tat Downregulates the Phosphorylation of Recepteur D'origine Nantais (RON) Receptor Tyrosine Kinase Induced by Macrophage-Stimulating Protein

HIV-1 Tat enhances purinergic P2Y4 receptor signaling to mediate inflammatory cytokine production and neuronal damage via PI3K/Akt and ERK MAPK pathways

Neurovirulent and non-neurovirulent strains of HIV-1 and their Tat proteins induce differential cytokine-chemokine profiles

HIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous system

Enhanced NF-κB activation via HIV-1 Tat-TRAF6 cross-talk

Effects of HIV-1 Tat on Secretion of TNF-α and IL-1β by U87 Cells in AIDS Patients with or Without AIDS Dementia Complex.

Short‐term exposure to HIV Tat induces glial activation and changes in perineuronal nets

Doxycycline-inducible and Astrocyte-Specific HIV-1 Tat Transgenic Mice (itat) As an HIV/neuroAIDS Model

Molecular Mechanism(s) Involved in the Synergistic Induction of CXCL10 by Human Immunodeficiency Virus Type 1 Tat and Interferon-Γ in Macrophages

HIV Tat Protein Induces Myocardial Fibrosis Through TGF-β1-CTGF Signaling Cascade: A Potential Mechanism of HIV Infection-Related Cardiac Manifestations

HIV-1 Tat Disrupts CX3CL1-CX3CR1 Axis in Microglia via the NF-kappa B-YY1 Pathway

Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline.

Hiv Tat Induces Expression Of Icam-1 In Huvecs: Implications For Mir-221/-222 In Hiv-Associated Cardiomyopathy

Combined Metabonomic and Quantitative Real-Time Pcr Analyses Reveal Systems Metabolic Changes in Jurkat T-Cells Treated with Hiv-1 Tat Protein

Activation of Egr-1 Expression in Astrocytes by HIV-1 Tat: New Insights into Astrocyte-Mediated Tat Neurotoxicity